This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Astrazeneca Ab. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Greg Christoph: Innovator in Pharmaceutical Chemistry
Introduction
Greg Christoph is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on crystalline forms of various compounds.
Latest Patents
Greg Christoph holds a patent for "Crystalline forms - 11-piperazin-1-yldibenzo[b,f][1,4]thiazepine, compositions thereof, preparations thereof, formulations thereof, prodrugs thereof and pharmaceutical uses thereof." This patent highlights his expertise in developing new pharmaceutical formulations that can enhance the efficacy of medications.
Career Highlights
Greg Christoph is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on advancing drug development and improving patient outcomes through innovative pharmaceutical solutions.
Collaborations
Throughout his career, Greg has collaborated with esteemed colleagues, including Simon D. Broady and Alan S. Kirschner. These collaborations have fostered a productive environment for research and development in the pharmaceutical industry.
Conclusion
Greg Christoph's contributions to pharmaceutical chemistry and his innovative patent work exemplify his commitment to advancing medical science. His ongoing efforts at AstraZeneca continue to impact the field positively.